Chronic clenbuterol administration alters myosin heavy chain composition in standardbred mares.
Authors: Beekley M D, Ideus J M, Brechue W F, Kearns C F, McKeever K H
Journal: Veterinary journal (London, England : 1997)
Summary
# Editorial Summary: Clenbuterol-Induced Shifts in Equine Muscle Fibre Composition Clenbuterol's effects on equine muscle have long intrigued performance professionals, yet its influence on the fundamental contractile properties of muscle tissue remains incompletely understood. Beekley and colleagues administered clenbuterol (2.4 µg/kg bodyweight twice daily) to unfit Standardbred mares over eight weeks, with some animals also undertaking moderate exercise (three 20-minute sessions weekly at 50% VO₂max), whilst measuring changes in myosin heavy chain (MHC) composition via muscle biopsy from the gluteus medius. Both clenbuterol-only and clenbuterol-plus-exercise groups exhibited significant fibre-type remodelling: type IIA fibres (the oxidative-glycolytic intermediates) declined by approximately 10 percentage points in each group, whilst type IIX fibres (fast-twitch, glycolytic) correspondingly increased by 12–13 percentage points; exercise alone produced no such shifts. This pharmacologically-induced transition towards faster, more glycolytic muscle phenotypes has important implications for practitioners considering clenbuterol use—whilst such a shift may enhance sprint capability in certain disciplines, it simultaneously reduces the aerobic capacity and fatigue resistance of working muscle, potentially compromising performance in endurance-demanding activities and altering training responses.
Read the full abstract on PubMed
Practical Takeaways
- •Clenbuterol use in performance horses shifts muscle toward faster, less fatigue-resistant fiber types (IIX), potentially limiting endurance capacity despite improved strength appearance
- •This fiber shift occurs independently of training stimulus, suggesting clenbuterol's effects override adaptive benefits from exercise conditioning
- •Practitioners should counsel clients that clenbuterol-induced changes in muscle composition may compromise long-distance performance and increase injury risk through altered muscle fatigue resistance
Key Findings
- •Clenbuterol administration (with or without exercise) significantly decreased MHC type IIA fibers by 10.5-10.4 percentage points in gluteus medius muscle
- •Clenbuterol administration significantly increased MHC type IIX fibers by 12.4-11.5 percentage points
- •Exercise alone produced no significant changes in MHC composition over the 8-week period
- •The shift toward faster, more fatigable fiber types occurred regardless of concurrent exercise training